APA

Curik N., Burda P., Vargova K., Pospisil V., Belickova M., Vlckova P., Savvulidi F., Necas E., Hajkova H., Haskovec C., Cermak J., Krivjanska M., Trneny M., Laslo P., Jonasova A. & Stopka T. (20121119). 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity. : Leukemia.

Chicago

Curik N, Burda P, Vargova K, Pospisil V, Belickova M, Vlckova P, Savvulidi F, Necas E, Hajkova H, Haskovec C, Cermak J, Krivjanska M, Trneny M, Laslo P, Jonasova A and Stopka T. 20121119. 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity. : Leukemia.

Harvard

Curik N., Burda P., Vargova K., Pospisil V., Belickova M., Vlckova P., Savvulidi F., Necas E., Hajkova H., Haskovec C., Cermak J., Krivjanska M., Trneny M., Laslo P., Jonasova A. and Stopka T. (20121119). 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity. : Leukemia.

MLA

Curik N, Burda P, Vargova K, Pospisil V, Belickova M, Vlckova P, Savvulidi F, Necas E, Hajkova H, Haskovec C, Cermak J, Krivjanska M, Trneny M, Laslo P, Jonasova A and Stopka T. 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity. : Leukemia. 20121119.